Methodist’s Generics Gallium68 Edotreotide Receive Approval in US
10 Oct 2025 //
FDA
CMS Grants Transitional Pass-Through Status for Gozellix
23 Sep 2025 //
GLOBENEWSWIRE
Telix Begins Phase 3 BiPASS Trial: PSMA-PET for Prostate Cancer
09 Sep 2025 //
GLOBENEWSWIRE
Gozellix Granted Permanent HCPCS Code
09 Jul 2025 //
GLOBENEWSWIRE
Telix partners with Cardinal Health for Gozellix distribution
08 Apr 2025 //
GLOBENEWSWIRE
ARTMS Drug Master File for Gallium Production Technology Referenced
01 Apr 2025 //
GLOBENEWSWIRE
ARTMS Announces Health Canada Submission for Ga-68 Production & Collaboration
14 Oct 2021 //
BUSINESSWIRE
Japanese Prostate Cancer Imaging Study Completes Enrolment
08 Sep 2021 //
GLOBENEWSWIRE
Telix Pharmaceuticals and GE Healthcare: Maximising 68Ga Supply
13 Oct 2019 //
BIOSPACE
Roche announces positive results from Gazyva/Gazyvaro phase 3 study
05 Dec 2016 //
PHARMABIZ

Market Place
Sourcing Support